'Vaccine effectiveness' presentation slideshows

Introduction to ACAM2000 Smallpox Vaccine

1.65k views • 99 slides

Considerations in Testing Vaccines in Developing Countries

Considerations in Testing Vaccines in Developing Countries. Zhi-yi Xu, MD, Wei Liu, MD International Vaccine Institute. Definition of Phases. Phase Study Population Principal Goal(s) 1 Healthy adults Safety;

561 views • 47 slides

Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance (SHIVERS)

Southern Hemisphere Influenza and Vaccine Effectiveness Research and Surveillance (SHIVERS). Comprehensive investigation of influenza epidemiology, aetiology, immunology and vaccine effectiveness US CDC 5 year funded project Started 2012. 9 objectives.

638 views • 46 slides

Epidemiological aspects of Vaccine Preventable Diseases (VPD)

915 views • 44 slides

Influenza Virus Vaccine Composition 2004-2005

Influenza Virus Vaccine Composition 2004-2005. Roland A. Levandowski, M.D. Division of Viral Products. Prepared for Vaccines and Related Biological Products Advisory Committee 18-19 February 2004. Topics for VRBPAC 18-19 February 2004. For Committee Recommendation:

604 views • 42 slides

Public Health Surveillance Systems

Public Health Surveillance Systems. Goals. Adverse events surveillance Syndromic surveillance Registries Laboratory data. Review purpose of surveillance Describe types of state and local surveillance systems: Vital records Disease reporting (morbidity data) Surveys

935 views • 36 slides

FOOT AND MOUTH DISEASE IN TURKEY

FOOT AND MOUTH DISEASE IN TURKEY. A. Naci BULUT Head of the Diagnosis Department Sap (FMD) Institute, ANKARA. P resentation o utlook. Introducing FMD (?ap) Institute Population size Outbreak situation Activities for suspection case and outbreak investigation

495 views • 31 slides

The Current Season: A Review of the 2003-04 Influenza Season

The Current Season: A Review of the 2003-04 Influenza Season. Nancy J. Cox, Ph.D. Chief, Influenza Branch National Center for Infectious Diseases Centers for Disease Control and Prevention. Timeline of Emergence of Influenza Viruses in Humans. Avian Influenza. H9. H7. Pandemic

471 views • 30 slides

Vaccines

Vaccines. Overview. Vaccine production methods Vaccine types and Diseases preventable by vaccines Vaccine modifications Routes of administration Reverse vaccinology Safety concerns about vaccination. What are vaccines Concept of drug and vaccines Vaccination and immunization concept

883 views • 27 slides

The 2006-07 Influenza Immunization Season: An Early Look at Communications and Media Planning Glen Nowak, Ph.D.

670 views • 19 slides

Case Study Pathogenic Bacteriology 2009

Case Study Pathogenic Bacteriology 2009. Case #41 Angela Augustus. Case Summary. 13 month old HIV negative Up to date on immunizations Initial symptoms: runny nose, low grade fever Treated with Tylenol Later in the day: Seizures Lethargic, limp, unresponsive, post ictal

567 views • 18 slides

Case Study MICR 420 Emerging and Re-Emerging Infectious Diseases S2010

Case Study MICR 420 Emerging and Re-Emerging Infectious Diseases S2010. Case 10 Jessica Cisneros Susana Hernandez. Case Summary. 3 yr old male Acute illness with four day history of fever, fever was reduced with Tylenol Patient experiencing fatigue

416 views • 13 slides

Influenza Virus Vaccine 2009-2010 Strain Selection

424 views • 13 slides

Measles Case Study: Afghanistan

Measles Case Study: Afghanistan. Afghanistan Case Study. Question 1 Are you concerned?. Is vaccination coverage really high? What was vaccine effectiveness Every year susceptible accumulating Case fatality rates may be high because of malnutrition Diarrhea may contribute to malnutrition

265 views • 8 slides

ABSTRACT

The Evaluation of the Effectiveness of the Trivalent Influenza Vaccine for the Prevention of Hospitalizations Due to Influenza Pneumonia; Results from the Rapid Empiric Treatment with Oseltamivir Study (RETOS )

98 views • 1 slides